Business
Adipocell™ Stem Cell Therapy Shows Safety In A Wide Variety of Applications
Adipocell™ Stem Cell Therapy Shows Safety In A Wide Variety of Applications.
About this update from U.s. Stem Cell, Inc.
[{"type":"text","content":"\n\n\n\nAdipocell™ Stem Cell Therapy Shows Safety In A Wide Variety of Applications\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nAdipocell™ Stem Cell Therapy Shows Safety In A Wide Variety of Applications\nChief Scientific Officer to Present Data at Worldwide Conference\nPR Newswire\nMIAMI, Dec. 1, 2017\n\n\n\nMIAMI, Dec. 1, 2017 /PRNewswire/ -- U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced its Chief Science Officer Dr. Kristin Comella will present at the Healthy Masters Worldwide Forum, Saturday, Dec. 2.\n\n\n \n \n\n \nDr. Comella, who is a global leader in the development of revolutionary holistic stem cell therapies, will discuss progress in the wide use of stem cells from a patient's own adipose (fat) tissue, which offer a novel therapy for damaged tissue from a variety of indications including orthopedic, autoimmune, degenerative and neurological diseases.  Her presentation, entitled \"Regenerative Medicine: The Future of Medicine is Here,\" includes results of a safety study and a knee study — each of which indicate stem cells harvested using USRM's proprietary Adipocell™ procedures are safe and effective, respectively, and are a novel therapy for patients with damaged tissue. \n\nAdipocell™ is a kit of disposables and reagents used to isolate a patient's own stem cells from fat, which is collected via an outpatient procedure.  Once harvested and isolated, stromal vascular fraction (SVF) is injected into patients which may reduce inflammation, promote healing, and repair damaged/scarred tissue. The SVF population includes mesenchymal stem cells (MSCs), pericytes, endothelial/progenitor cells, fibroblasts and growth factors where the adipocyte (fat cell) population has been removed. \n\nIn the safety study, which was published in the Journal of Clinical Medicine Research, an in-clinic use of stromal vascular fraction (SVF) was used for degenerative diseases in orthopedics, neurological conditi...